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Abstract We previously showed that starvation causes revers-
ible hyperphosphorylation of tau in the mouse brain. To explore
possible involvement of stress in tau hyperphosphorylation quan-
titative analysis of phosphorylated tau in four brain regions of
mice subjected to cold water stress (CWS) was made by immu-
noblot analyses using phosphorylation-dependent antibodies di-
rected to eight sites on tau known to be hyperphosphorylated in
the brain of Alzheimer’s disease (AD) patients. Ser199, Ser202/
Thr205, Thr231/Ser235 were hyperphosphorylated 20 and 40
min after CWS. The response was pronounced in the hippocam-
pus and cerebral hemisphere, but weak in the cerebellum in
parallel with the regional vulnerability in AD. Among the reg-
ulatory phosphorylation of protein kinases studied, a transient
phosphorylation of tau protein kinase I/glycogen synthase ki-
nase 3L at Ser9 was most conspicuous.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Tau phosphorylation; Protein kinase;
Hippocampus; Mouse; Cold water stress; Alzheimer’s disease
1. Introduction
Alzheimer’s disease (AD) is characterized by accumulation
of senile plaques and neuro¢brillary tangles (NFT) in the
brain. NFT mainly consist of highly phosphorylated tau pro-
teins [1]. In AD brains tau is phosphorylated at a number of
sites [2,3] resulting in a reduced ability to bind microtubules
[4]. Discovery of mutations in the tau gene as causes of a form
of dementia (FTDP-17) has directed increasing attention to
tauopathy as a possibly central pathogenetic process in a
number of neurodegenerative diseases such as AD [5].
We recently discovered that food deprivation causes pro-
gressive phosphorylation of tau in the normal mouse brain at
six sites that are all characteristically highly phosphorylated in
AD brain [6]. The enhancement of tau phosphorylation was
most prominent in the hippocampus, followed by the cerebral
cortex, and minimal in the cerebellum, in parallel with the
known rank order of vulnerability to NFT pathology of brain
regions in AD patients [7,8]. The discovery raised not only the
question of the physiological signi¢cance of the reversible tau
phosphorylation in the normal brain, but also the possibility
of involvement of a common mechanism in early stages of AD
pathogenesis. We therefore set out to explore whether other
stressful stimuli will cause in vivo phosphorylation with char-
acteristics possibly relevant to AD.
Forced swimming of rodents in cold water is one of the
established experimental systems employed in the studies of
stress. Korneyev observed an increased tau phosphorylation
caused by cold water stress (CWS) in the rat brain [9]. Only
soluble tau fractions were analyzed by enzyme-linked immu-
nosorbent assay with two phosphorylation-dependent anti-
bodies. Phosphorylation of tau at one site was reported in
the obese strain of mouse after CWS [10]. These pioneering
studies, however, were limited in the number of phosphory-
lation sites examined, and the wild-type mice remained to be
studied. We have now made a quantitative immunoblot anal-
ysis of phosphorylation levels of SDS-solubilized tau at seven
independent sites for four regions of the normal mouse brain
after CWS. The time course and the extent of phosphory-
lation were found to depend on the site on tau protein, and
also on the brain region. Changes in the levels of regulatory
phosphorylation of tau protein kinase I/glycogen synthase ki-
nase 3L (TPKI/GSK3L), Erk2 and p46 JNK (c-Jun N-termi-
nal kinase) protein kinases were found.
2. Materials and methods
2.1. Animals
Male C57BL/6Njcl mice of 10^13 weeks of age (Clea Japan, Tokyo,
Japan) weighing 25.0F 3.0 g were housed in groups of four and al-
lowed free access to food and water. A total of 59 mice maintained at
23‡C and under the light period of 08:00^20:00 were used in com-
pliance with the protocols approved by the Animal Care and Use
Committee of Mitsubishi Kagaku Institute of Life Sciences.
2.2. CWS
CWS was given between 13:00 and 18:00. Mice were immersed up
to the neck in ice-cold water of 5 cm depth in a 16 cm diameter
ceramic container for 5 min, after which they were gently wiped dry
and returned to the cages. Mice were killed by cervical dislocation at
20, 40 and 90 min after CWS.
2.3. Western blotting
The brains were removed immediately after sacri¢ce and placed in
ice-chilled saline. Desired brain regions were quickly removed by man-
ual direction: hippocampus, ventroposterior quadrant of the cerebral
hemisphere (VP), the rest of the cerebral hemisphere (RH) and cer-
ebellum. The tissues were immediately homogenized using a Physco-
tron Microhomogenizer (Microtech Nichion, NS-310E) in 10 times
volume/tissue weight of O+ bu¡er (62.5 mM Tris^HCl, pH 6.8,
10% (w/v) glycerol, 5% (v/v) 2-mercaptoethanol, 2.3% (w/v) SDS,
5 mM NaF, 100 WM orthovanadate, 1 WM okadaic acid, 1 mM
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PMSF, 1 mM EDTA, 1 mM EGTA). The homogenates were imme-
diately placed in boiling water for 3 min. Protein concentration was
determined after 20 times dilution with saline by the Bio-Rad Protein
Assay with bovine serum albumin (BSA) in O+ bu¡er as standard.
Appropriate amounts of samples (4 Wg protein/lane for tau antibodies
except for PS422, and 18 Wg/lane for PS422 and all kinase antibodies)
were run on 10% SDS^PAGE and electrophoretically transferred to
nitrocellulose membrane (Protran BA 85, Schleicher and Schuell) for
60 min at 8 V in a semi-dry blotting apparatus (Bio-Rad, Trans-Blot
SD Cell). Membrane was blocked in phosphate-bu¡ered saline (PBS)
containing 10% (w/v) skim milk and 0.5% Tween 20 (Sigma) for 1 h,
followed by incubation with primary antibodies for 2 h, washing in
PBS with 0.1% Tween 20, and then by incubation with secondary
antibodies conjugated to horseradish peroxidase (Pierce, ImmunoPure
Goat Anti-Rabbit IgG (H+L) Peroxidase Conjugated, or Immuno-
Pure Goat Anti-Mouse IgG (H+L) Peroxidase Conjugated, each at
1:10 000) for 1 h at room temperature. For immunoblotting with anti-
kinase antibodies, the blots were blocked with Tris-bu¡ered saline
containing 0.1% Tween 20 (TBST). Primary and secondary antibodies
were diluted in TBST containing 5% BSA and TBST containing 5%
skim milk, respectively. After washing, the blots were soaked in
SuperSignal West Pico Chemiluminescent Substrate (Pierce), and the
signals were quanti¢ed with a luminescence image analyzer (LAS-
1000plus, Fuji¢lm) and Image Gauge 3.0 software (Fuji¢lm), followed
by statistical evaluation by analysis of variance. In separate experi-
ments analyzing various amounts of a standard sample we con¢rmed
approximate linear correspondence between the integrated band in-
tensity values and the input protein under the conditions here em-
ployed.
2.4. Antibodies
Rabbit a⁄nity-puri¢ed antibodies PS199, PT231/PS235, PS262,
PS396, and PS422 are speci¢c to tau phosphorylated at the residue
indicated, and Tau-C recognizes the C-terminal epitopes of tau
[11,12]. Mouse monoclonal antibody AT8 (Innogenetics) recognizes
tau dually phosphorylated at Ser202 and Thr205. Rabbit antibody
PS9 recognizes TPKI/GSK3L phosphorylated at Ser9, and antibody
PY216 recognizes TPKI/GSK3L phosphorylated at Tyr216 and
GSK3K phosphorylated at Tyr279 [13]. Anti-TPKI mouse monoclo-
nal antibody T1.7 was produced by immunizing a BALB/c mouse
against a C-terminal peptide of rat tau [14]. Anti-cdk5 and anti-p35
C-terminus antisera were described [15,16]. Other rabbit antibodies
used to analyze various protein kinases were commercially obtained:
anti-ACTIVE JNK pAb (pTGpY) (Promega), JNK1 (Santa Cruz),
anti-phospho-p44/42 mitogen-activated protein kinase (MAPK)
(Thr202/Tyr204) antibody (NEB), anti-Erk1/2 pAb (Promega).
3. Results
3.1. Phosphorylation patterns of tau in the mouse hippocampus
after CWS
In AD brains tau is hyperphosphorylated, and a recent
study has shown that PHF-tau is phosphorylated in at least
25 sites [3]. Changes in phosphorylation levels of tau in the
mouse brain after CWS were studied with respect to seven of
such sites for which speci¢c antibody probes were available.
Mice were put in ice-chilled water for 5 min, and after various
periods of recovery, four brain regions were quickly taken:
the hippocampus (HC), the VP (containing entorhinal cortex
and amygdala), the RH (containing striatum), and the cere-
bellum (CB). Aliquots containing equal amounts of protein
were analyzed by quantitative immunoblotting using phos-
phorylation-dependent site-speci¢c anti-tau antibodies (Fig.
1B^H). Changes in the phosphorylation state of tau are re-
£ected in altered signal intensities of tau bands, and also by
discrete mobility shifts characteristic of phosphorylated tau
[17].
In immunoblots of Fig. 1, each lane shows bands obtained
for one representative mouse out of four analyzed for each
time point. Tau in the hippocampus of unstressed control
mice occurred mostly in the fastest migrating band 1 as re-
vealed by the phosphorylation-independent antibody, Tau-C
(Fig. 1A, leftmost lane). After 20^40 min following CWS, a
large portion of tau was found in the retarded bands 2^4,
accompanied by a diminished intensity of band 1. The band
1 regained intensity, with diminution of bands 2^4, after 90
min. These results suggest, by virtue of known phosphory-
lation-dependent mobility shift, a transient rise in tau phos-
phorylation level after CWS.
Direct phosphorylation signals obtained with seven anti-
bodies recognizing distinct phosphorylated sites are displayed
in Fig. 1B^H, the ¢rst column for the hippocampus (HC). For
antibodies PS199, AT8, and PT231/PS235 (Fig. 1B^D) the
signals were barely detected in the control mice, whereas a
robust staining mostly in band 2 appeared at 20 and 40 min
after CWS, which declined toward 90 min. For three other
antibodies, PS396, PS404, and PS422 (Fig. 1F^H), the phos-
phorylation signals were detected in the basal band 1 in the
controls. After CWS the signals for the antibodies PS396 and
PS404 showed transient massive mobility shifts to band 2
(Fig. 1F,G), that largely reverted toward 90 min. Quantitative
results obtained by integrating band intensities for four mice
at each time point are shown in Fig. 1I^P. No signi¢cant
changes in integrated band intensity were observed at
Ser262 in the hippocampus (Fig. 1M), while a transient de-
crease was seen for Ser422 (Fig. 1P).
These results show that rapid and reversible phosphory-
lation of tau at multiple phosphorylation sites takes place in
the hippocampus of mice during recovery from stress of CWS.
The overall pattern of phosphorylation at the height of re-
sponse to CWS was broadly similar to that attained in the
hippocampus after 2 days of starvation [6], and also to PHF-
derived tau from AD brains [2,3].
3.2. Phosphorylation patterns of tau in the cerebral cortex and
cerebellum after CWS
In our previous study of starved mice, changes in tau phos-
phorylation were robust in the hippocampus but minimal in
the cerebellum [6]. Analysis of tau phosphorylation after CWS
was made also of the cerebral and neocortical tissues of the
same set of mice as used for the hippocampal study. The ce-
rebral hemisphere was divided into a ventroposterior quad-
rant (VP) and the rest (RH) because of particular interest in
the entorhinal and amygdalar tissues with strong connectivity
to the hippocampus.
When compared on the basis of total extracted protein, the
C
Fig. 1. Increased phosphorylation and electrophoretic mobility shifts of tau in four regions of the mouse brain after CWS. Mice underwent
5 min of CWS and recovered for 20, 40, or 90 min before sacri¢ce and removal of brain. Control mice received no CWS (cont). Panels A^H
show immunoblots of extracts from one representative mouse out of four analyzed for each time point. Panel A was probed with Tau-C anti-
body speci¢c to tau and independent of phosphorylation. Panels B^H are immunoblots obtained with site-speci¢c phosphorylation-dependent
tau antibodies as indicated. Bands 1^4 of tau (apparent molecular weights: 56, 60, 64, and 70 kDa) are indicated at the left. Panels I^P are a
quantitative presentation of band intensities as functions of time and brain region at respective epitopes. Signi¢cant di¡erence from control at
P6 0.01 and P6 0.05 are denoted by ** and *, respectively, and likewise in Figs. 2 and 3.
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cerebellum had a comparable content of tau protein as the
hippocampus (Fig. 1A,I). The phosphorylation level of tau,
however, was much lower, and hyperphosphorylation was not
observed after CWS apart from weak changes at Ser199 and
AT8.
In the hemispheric regions VP and RH, the temporal
changes in the phosphorylation levels at respective sites were
qualitatively similar to that observed in the hippocampus,
with the exception of Ser262, where clear hyperphosphoryla-
tion was seen at 20 and 40 min in contrast to the hippocam-
pus. The level of phosphorylation on the basis of equal total
protein attained at 40 min was higher in VP than in RH for
the epitopes of PS199, AT8, PT231/PS235, and PS262.
These results show that CWS-induced tau phosphorylation
takes place in the cerebral hemispheres in a pattern broadly
similar to that in the hippocampus, and that the phosphory-
lation level of tau in the cerebellum is basically unresponsive
to CWS.
3.3. Protein kinases after CWS
Previous studies showed that tau can be phosphorylated in
vitro by a number of protein kinases [18,19], including TPKI/
GSK3L, tau protein kinase II (TPKII) consisting of cdk5 and
p25, Erk1 and 2, JNK, and p38 kinase. Cotransfection experi-
ments have shown phosphorylation of tau in cells by TPKI/
GSK3L and by TPKII [20^22]. The kinases responsible for
phosphorylating tau in the brain, however, remain to be es-
tablished. As a ¢rst step to clarifying the mechanisms of
CWS-induced tau phosphorylation, the same set of tissue ho-
mogenates as used for Fig. 1 were analyzed with available
antibodies speci¢c to the phosphorylated state of several pro-
tein kinases (Fig. 2).
Ser199, Thr231, and Ser396 have been shown to be phos-
phorylated by TPKI/GSK3L [23]. Two regulatory phosphor-
ylation sites are known in this kinase. Phosphorylation of
Tyr216 is considered essential for TPKI/GSK3L activity [24],
and phosphorylation of Ser9 is associated with partial inhibi-
tion [25]. No signi¢cant change was observed in the phosphor-
ylation level of Tyr216 after CWS (Fig. 2A,E). On the other
hand, dynamic changes were observed at Ser9, whose phos-
phorylation level sharply rose after CWS and then declined
(Fig. 2A,G). During these experiments the protein level of
TPKI/GSK3L did not undergo signi¢cant changes (Fig.
3A,G).
TPKII phosphorylates tau in vitro at Ser202, Thr205,
Ser235 and Ser404 [26], and these sites were all highly phos-
phorylated in the mouse brain after CWS (Fig. 1). Protein
levels of cdk5, the catalytic subunit of TPKII, did not change
after CWS (Fig. 3I), but a mobility shift was observed with
p35, an activator of cdk5 (Fig. 3C, uppermost bands), indicat-
Fig. 2. Changes in the phosphorylation levels of several protein kinases after CWS. The same brain extracts as in Fig. 1 were analyzed by
quantitative immunoblotting with phosphorylation-dependent anti-protein kinase antibodies as indicated.
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ing possible activation of cdk5. The antibody used was di-
rected to the common carboxyl-terminus of p35 and p25, a
truncated form of p35 [16,27], yet no p25 band was detected
in our samples of mouse brain tissues (data not shown).
Ser199, Ser202, Ser235, Ser396 and Ser404 have been shown
to be phosphorylated by MAPK (Erk1 and 2) in vitro [28,29],
while Ser202 and Thr205 were reported to be the sites for
JNK action [30], and Ser202, Thr205, Thr231, Ser235,
Ser396 and Ser404 the sites for p38 kinase [29]. The phosphor-
ylation level of p42 MAPK (Erk2) underwent a transient de-
crease (Fig. 2H), while that of p46 JNK showed an increase
(Fig. 2J) after CWS. Protein levels of these isoforms did not
show signi¢cant changes up to 90 min after CWS (Fig. 3J^M).
No signi¢cant changes were observed in the phosphorylation
of p38 kinase (data not shown).
4. Discussion
Our quantitative immunoblot analysis found that CWS
causes a rapid and reversible enhancement of tau phosphory-
lation in the mouse brain at seven hydroxyl residues studied
that are highly phosphorylated in AD brains. This phenome-
non was pronounced in the hippocampus and in other parts
of the cerebral hemisphere (the hemispheric regions VP and
RH), but weak in the cerebellum.
4.1. Signi¢cance of tau phosphorylation
We previously showed that food deprivation of mice leads
to increased levels of tau phosphorylation, most notably in the
hippocampus. The patterns of tau phosphorylation with re-
spect to the six phosphorylation sites and of immunoblot
band shifts observed after 2 days of starvation [6] were similar
to those found in this study after CWS. Starvation is a form
of stress [31]. Papasozomenos studied tau phosphorylation in
the brain of heat-shocked rats using Tau-1 and PHF-1 mono-
clonal antibodies, and found elevated phosphorylation levels
only in female rats [32^34]. Korneyev showed a transient in-
crease in tau phosphorylation at PHF-1 and Tau-1 sites in the
rat hippocampus and other brain regions after CWS [9], and
an enhanced response at AT8 site in fat ob/ob mice compared
to lean ob/+ mice [10]. In this context, our ¢nding that forced
swimming in cold water causes in wild-type mice rapid and
robust hyperphosphorylation of brain tau at seven sites raises
a possibility that tau phosphorylation is an integral part of the
neural response to stressors in general.
Hippocampus is a nodal tissue in the control of neural
reactions to stress [35] as well as of declarative memory which
is a¡ected in early stages of AD [36]. In fact the AD neuro-
pathologies have been strongly associated with the hippocam-
pus, entorhinal cortex, and amygdala, and AD has been thus
recognized as limbic dementia [37]. Repeated restraint stress
Fig. 3. Relative invariance of protein levels of several protein kinases in the hippocampus after CWS. Quantitative immunoblotting made use
of phosphorylation-independent kinase-speci¢c antibodies as indicated.
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in the rat has been shown to exacerbate neuronal damage in
the hippocampus caused by a variety of excitotoxic and met-
abolic insults to the brain leading to memory loss [38]. It is
thus tempting to speculate that phosphorylation of tau is in-
volved in certain aspects of central processing of stress stimuli.
Certain di¡erences in tau phosphorylation and dephosphor-
ylation pattern were found among the phosphorylation sites
on tau examined above. The sites N-terminally £anking the
microtubule binding domain of tau (roughly amino acids 244^
367) [39] exhibited relatively crisp temporal changes in phos-
phorylation state compared to the C-terminally £anking sites.
Thus Ser199, Ser202, Thr205, Thr231, and Ser235 underwent
dramatic phosphorylation and dephosphorylation during 90
min after CWS, while Ser396 and Ser404 did not exhibit ap-
preciable changes in integrated phosphorylation levels as de-
tected by immunoblotting. Phosphorylation of Ser199 and
Thr231 by TPKI/GSK3L is facilitated by prior phosphory-
lation by TPKII of Ser202 and Ser235, respectively [11], and
phosphorylation of Ser202 and Thr205 by TPKII is stimu-
lated by microtubules [40]. These ¢ndings together suggest
that the phosphorylation events at sites in the two £anking
regions may subserve distinct roles in the function of hyper-
phosphorylated tau.
4.2. Involvement of protein kinases
In an initial e¡ort to probe into the molecular mechanisms
of regulation of tau phosphorylation after CWS, we studied
the phosphorylation levels of protein kinases implicated in tau
phosphorylation and for which phosphorylated form-speci¢c
antibodies were available (Fig. 2). Immunoblot analyses with
phosphorylation-independent anti-protein kinase antibodies
indicated that protein levels of the protein kinases studied
remained largely invariant during the period after CWS
studied (Fig. 3).
TPKI/GSK3L has been shown to phosphorylate tau pro-
ducing a characteristic mobility shift [20,41^43] and is consid-
ered to be a most plausible protein kinase to confer PHF-like
changes on tau in the human brain [18,44^46]. It is therefore
intriguing that the most dynamic change in kinase phosphor-
ylation after CWS was observed at Ser9 of TPKI/GSK3L
(Fig. 2). As phosphorylation at this site is reported to lead
to a decreased kinase activity (as assayed using substrates
such as inhibitor 2, c-Jun, and a peptide from glycogen syn-
thase, but not tau, [25]), increased Ser9 phosphorylation needs
to be reconciled with the observed increased phosphorylation
at Ser199, Thr231, and Ser396 of tau (Fig. 1), the sites shown
to be phosphorylated by TPKI/GSK3L in vitro [23]. The de-
creased kinase activity of TPKI/GSK3L may be o¡set by an
even larger decrease in protein phosphatase(s) responsible for
dephosphorylation of tau at these sites. Alternatively, phos-
phorylation of Ser9 may entail an altered substrate speci¢city
of the protein kinase or an altered interaction with other
proteins such as sca¡old proteins, bringing about tau hyper-
phosphorylation in vivo. A third intriguing possibility is that
an increase in Ser9 phosphorylation may be a secondary con-
sequence of increased tau phosphorylation through some neg-
ative feedback regulation impinging upon TPKI/GSK3L.
Each of these possibilities warrants careful examination.
Phosphorylation of tau by TPKII/cdk5+p25 facilitates sub-
sequent phosphorylation by TPKI/GSK3L [11], and cdk5 is
another strong candidate kinase implicated in tau phosphor-
ylation leading to neuronal dysfunction [18,22,47]. In our
analysis p25 was not detected, but p35, a cdk5 activator,
underwent a mobility shift after CWS, likely due to phosphor-
ylation (Fig. 3C). Recent studies suggest that p35 is phosphor-
ylated by cdk5 leading to proteolytic cleavage by proteasome
[48,49]. This may indicate a transient activation of cdk5, fol-
lowed by regulatory down regulation through p35 degrada-
tion, in the mouse brain after CWS.
Activation after CWS was also seen with p46 JNK (Fig.
2J). Interestingly, JNK activation in the mouse brain after
restraint stress and novel environmental stimulation has
been described [50]. JNK may be involved in phosphorylation
at the AT8 epitope (PS202/PT205). A transient decrease in the
phosphorylation level of p42 MAPK/Erk2 was found (Fig.
2C,H). This kinase is involved in a complex network of reg-
ulatory phosphorylation signaling in neurons [51], and the
signi¢cance of its transient dephosphorylation after CWS re-
mains to be clari¢ed. Our ¢ndings with the various protein
kinases indicate that the dynamic changes of tau phosphory-
lation we observed after CWS are likely to be the result of a
complex regulatory network of protein kinases and phospha-
tases, and not to be ascribed to a single signal cascade [52].
Such a line of thinking encourages us to envisage a possibility
that tau phosphorylation may represent an integral part of the
normal molecular signal processing machinery, such as tran-
scriptional regulation, beyond simply e¡ecting a decrease in
its a⁄nity to microtubules [4].
Further studies are needed to understand fully the physio-
logical signi¢cance of tau phosphorylation in the brain upon
stress. Pharmacological analyses targeting protein kinases and
phosphatases as well as stress hormones will be necessary to
delineate the molecular mechanisms involved. It is hoped that
further insights into the molecular consequences of stress in
the brain will shed important light on the intriguing corre-
spondence in regional susceptibility of tau pathology in AD
on the one hand and stress-related physiological hyperphos-
phorylation on the other.
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